# Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets in Chronic Endometritis

> **NCT06650540** · NA · NOT_YET_RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 800 (estimated)

## Conditions studied

- IVF

## Interventions

- **DRUG:** Levofloxacin Plus Metronidazole Suppositories
- **BIOLOGICAL:** Levofloxacin co-administered with Metronidazole tablets

## Key facts

- **NCT ID:** NCT06650540
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-22
- **Primary completion:** 2025-10-22
- **Final completion:** 2026-12-30
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2024-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06650540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06650540, "Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets in Chronic Endometritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06650540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*